Trial intelligence / Profile preview

PUMP STUDY: MDI Lantus/Lispro vs CSII

NCT00540709Phase 4Completed

Sponsor
Sanofi
Start
Nov 2002
Primary completion
Sep 2003
Modality
Recombinant Proteins and Enzymes
01

Overview

A Phase 4 trial of insulin glargine in type 1 diabetes mellitus (T1D), sponsored by Sanofi. Started Nov 2002; status: completed.

02

Drugs

insulin glargine
03

Conditions

type 1 diabetes mellitus (T1D)

Beyond the preview

Go deeper on NCT00540709.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00540709.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call